Projections of zoster incidence in Australia based on demographic and transmission models of varicella-zoster virus infection
- PMID: 29050801
- DOI: 10.1016/j.vaccine.2017.09.090
Projections of zoster incidence in Australia based on demographic and transmission models of varicella-zoster virus infection
Abstract
Re-exposure to varicella infection is believed to delay the occurrence of herpes zoster (HZ), which has led to predictions of increased HZ following introduction of varicella vaccination programs. However, there is evidence of rising HZ rates before vaccination was introduced. Here, we explore a potential explanation for this effect through demographic change leading to reductions in varicella exposure and boosting in the context of Australia over the 20th century. To study this hypothesis, we integrated observed changes in Australian birth and age-specific death rates with a varicella transmission model. The model was then calibrated to age-specific pre-vaccination seroprevalence (1997-9) and hospitalization data (1993-2009). Model simulations predicted that declining birth rates led to a 50% reduction in varicella incidence over the 20th century. When combined with the impacts of an aging population, the simulations further suggested that HZ incidence should have increased by 50% over the 20th century. However, we found that after age-standardization, the residual increase in HZ due to reduced boosting was only about 8% over the 20th century. Results were also sensitive to the assumed duration of immunity to HZ and whether multiple HZ episodes were possible. Despite a strong predicted effect of demographic change on varicella incidence, our findings suggest that improved survival is the main contributor to any rise in HZ rates prior to vaccination in Australia. Removing survival effects through age-standardization is recommended when considering epidemiologic or model-based analysis of past trends in HZ.
Keywords: Age standardization; Demographic changes; Herpes zoster; Modeling; Varicella.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.EBioMedicine. 2015 Aug 8;2(10):1494-9. doi: 10.1016/j.ebiom.2015.08.017. eCollection 2015 Oct. EBioMedicine. 2015. PMID: 26629544 Free PMC article.
-
The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study.Proc Biol Sci. 2015 Apr 7;282(1804):20142509. doi: 10.1098/rspb.2014.2509. Proc Biol Sci. 2015. PMID: 25761709 Free PMC article.
-
Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.Vaccine. 2018 Feb 14;36(8):1116-1125. doi: 10.1016/j.vaccine.2018.01.038. Epub 2018 Jan 20. Vaccine. 2018. PMID: 29366704
-
The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.J Infect Dis. 2008 Mar 1;197 Suppl 2:S224-7. doi: 10.1086/522162. J Infect Dis. 2008. PMID: 18419401 Review.
-
Herpes zoster in the context of varicella vaccination - An equation with several variables.Vaccine. 2018 Nov 12;36(46):7072-7082. doi: 10.1016/j.vaccine.2018.09.013. Epub 2018 Oct 8. Vaccine. 2018. PMID: 30309745 Review.
Cited by
-
Incorporating human dynamic populations in models of infectious disease transmission: a systematic review.BMC Infect Dis. 2022 Nov 18;22(1):862. doi: 10.1186/s12879-022-07842-0. BMC Infect Dis. 2022. PMID: 36401210 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous